THYROCARE - Thyrocare Technologies

Thyrocare Technologies

THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth

2.1%

12.0%

30.8%

13.5%

5.7%

39.7%

13.7%

all

6.3%

🤔 How to analyze this graph?

Last Traded Price

₹ 890 2.1%

658

939

Company Overview

Sales

687 Cr

Growth: 15.4%

Profit after Tax

91.6 Cr

Growth: 4.5%

Small Cap

4,716 Cr

P/E: 52.8x

Industry P/E: 51.6x

Fundamentals

Sales (Cr)	₹ 687
Growth	15.4%
EBITDA	27.7%
P/S	7.0x
Dividend	2.0%
P/E	52.8x
Book Value	₹ 103
PEG Ratio	3.4x
ROE	16.1%
P/B	8.8x

Shareholding Pattern

Institutions

Arisaig Asia Consumer Fund Limited

6.11 %

Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund

3.57 %

Fundsmith Emerging Equities Trust Plc

1.46 %

Promoters

Dr.A.Velumani

28.02 %

Thyrocare Publications Llp

12.36 %

Thyrocare Properties And Infrastructure Private Imited

9.88 %

A.Sundararaju Huf

4.57 %

Sumathi Infra Project Llp

2.98 %

Others

Bakak Financial Securities

2.84 %

Llp

0.13 %

Increase Decrease No change

Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.

Belongs to (8 Indices) view more

Investors (83)

nomura.i...

sbi.magn...

norwest....

Followers (23)

surendra...

anshuman

gagan